Congratulations! Chuangyuan Biotechnology has once again been granted a national invention patent.

On August 2, 2022, Tianjin Chuangyuan Biotechnology Co., Ltd. independently developed and applied for the patent titled "A Curved Lactobacillus IOB901 and Its Application in Reducing Blood Sugar and Lipids" (Patent No. 202210417264.1).The National Intellectual Property Administrationofficially issued the invention patent certificate.

This invention patent represents another breakthrough innovation in the field of functional probiotics research by Chuangyuan Biotechnology. The company's researchers selected and isolated excellent probiotics more suitable for the Chinese constitution from the natural environments of healthy human intestines and traditional Chinese fermented foods, using an industrially feasible bionic digestion system constructed in vitro for fermentation, applying internationally advanced segmented solid-state fermentation technology for probiotics.A specialized formula was developed and a patent was applied for. This invention can be applied tospecial dietary foods, special medical foods, health ecological foods, intestinal microecological preparations, biomedicine, and health, among other fields.

The acquisition of this invention patent certificate is not only a high recognition of Chuangyuan Biotechnology's product development and technological innovation but also showcases the company's long-standing commitment to independent research and development. Chuangyuan Biotechnology's research capabilities, technological innovation, and application levels in the field of functional probiotics have been recognized by the state.

Chuangyuan Biotechnology is a Sino-American joint venture national high-tech enterprise, based on various internationally advanced segmented solid-state fermentation technologies for probiotics. It integrates research and development, production, sales, and services, specializing in special dietary foods, health ecological foods, and intestinal microecological preparations. Since its establishment, the company has closely collaborated with many well-known universities and authoritative research institutions both domestically and internationally, such as Harvard University, National University of Singapore, Tianjin University of Science and Technology, and the National Key Laboratory of Food Nutrition and Safety co-established by provincial and ministerial departments, to build research and development platforms and empower technological innovation. To date, over 30 million yuan has been invested in research and development, with 18 invention patents, 24 utility model patents, and over 30 products launched in the market. The company has established a functional probiotic strain bank with over 3,000 strains, and 16 core functional probiotics are preserved at the Institute of Microbiology, Chinese Academy of Sciences.

Currently,the second-phase production base and key laboratory project for microecological preparations of Chuangyuan Biotechnologyis under construction and is expected to be completed and put into production by the end of 2022. This project covers an area of 51 acres, with a total investment of 250 million yuan, and will focus on an Industry 4.0 intelligent factory, a key experimental platform for microecological preparations, and a special medical technology platform, promoting the company's in-depth development in the field of biotechnology and further enriching its strategic layout.

patent, postbiotics, Chuangyuan Biotechnology, probiotics, invention patent

Chuangyuan Biological's probiotic solid-state fermentation technology for the preparation of postbiotics powder has been granted a national invention patent.

Deep Empowerment and Cooperation Upgrade | Warmly welcome Feihe Ranch to visit Tianjin Chuangyuan Biotechnology

Chuangyuan Biological's probiotic solid-state fermentation technology for the preparation of postbiotics powder has been granted a national invention patent.

Deep Empowerment and Cooperation Upgrade | Warmly welcome Feihe Ranch to visit Tianjin Chuangyuan Biotechnology

2024-12-23

In December 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. and Haihe Dairy jointly held a series of themed activities titled "Party Building Mutual Visits and Learning" to further promote the deep integration of both parties' party building work and business development. During the event, both sides will conduct company visits and on-site discussions. Recently, Haihe Dairy made an initial visit and, after gaining a deep understanding of Chuangyuan Biotech's products, expressed high recognition and close attention, laying a solid foundation for future cooperation. Subsequently, both parties engaged in detailed communication on the core topics of "exchange of party building experiences and sharing of business resources," discussing standardized construction of party branches, distinctive party building measures, and the promotion of party-business integration. They also conducted in-depth exchanges on aspects such as corporate cooperation, product intercommunication, and information sharing, jointly exploring new paths for the development of the health industry under the guidance of party building, providing more possibilities for further establishing a "symbiotic, mutually promoting, and win-win" cooperative relationship. Both parties hope to achieve industrial resonance through party building leadership and contribute to the development of the health industry in the Binhai New Area.

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

2024-12-17

On December 16, 2024, the 22nd China Food Safety Conference and the 2024 National Food Industry Science and Technology Progress Conference, themed "Implementing Food Safety Strategy to Support the Construction of a Healthy China," was grandly held in Beijing. During the conference, the award ceremony for the 2024 National Food Industry Science and Technology Progress Conference was also held. Tianjin Chuangyuan Biotechnology Co., Ltd. won the second prize for scientific and technological progress in the "2023 China Food Industry Association Science and Technology Award" for two projects: "Key Technology Breakthrough and Industrial Application of New Postbiotics Segmented Solid-State Fermentation" and "Development and Application of Key Technologies and Equipment for Plant Polysaccharide Efficacy Verification and Extraction."

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

2024-12-13

On December 13, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder (Patent No.: ZL 202411354886.X). This invention provides a method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder, which relates to the field of microbiology. The Lactobacillus plantarum IOB701 was preserved on July 10, 2018, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation address at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number CGMCC No. 16077. Using grains or legumes treated with low oxygen stress as the fermentation substrate, the Lactobacillus plantarum IOB701 fermentation resulted in postbiotics powder, which, according to animal experiments, has been shown to improve chronic unpredictable mild stress-induced depressive-like behavior in mice.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Jin Gong Wang An Bei No. 12019202000539

Business License